Pfizer Inc
- SEC CIK
- 0000078003
- Latest filing
- Aug 13, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 13, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 21
- −2 vs. Q4 2024
- Portfolio value
- $500.8M
- −$2.09B (−80.7%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BNTXBioNTech SE | SPONSORED ADS | 3,658,361 | $333.1M | 66.5% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 22,032,040 | $32.2M | 6.4% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 5,376,344 | $30.0M | 6.0% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 3,457,815 | $24.3M | 4.8% | 00.0% | Unchanged | History |
| TRMLTourmaline Bio, Inc. | COM | 1,272,214 | $19.4M | 3.9% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 1,875,000 | $15.2M | 3.0% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 505,645 | $12.2M | 2.4% | 00.0% | Unchanged | History |
| CRDFCardiff Oncology, Inc. | COM | 2,411,575 | $7.57M | 1.5% | 00.0% | Unchanged | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 7,032,770 | $6.89M | 1.4% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 4,690,431 | $4.28M | 0.9% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,970,022 | $3.83M | 0.8% | 00.0% | Unchanged | History |
| CELCCelcuity Inc. | COM | 349,406 | $3.53M | 0.7% | 00.0% | Unchanged | History |
| EPIXESSA Pharma Inc. | COM NEW | 1,675,000 | $2.65M | 0.5% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 2,362,348 | $1.70M | 0.3% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 953,834 | $1.52M | 0.3% | 00.0% | Unchanged | History |
| ANTXAN2 Therapeutics, Inc. | COM | 715,295 | $972.8K | 0.2% | 00.0% | Unchanged | History |
| NXTCNextCure, Inc. | COM | 1,891,763 | $908.6K | 0.2% | +433,213+29.7% | Added | History |
| QTTBQ32 Bio Inc. | COM | 277,777 | $458.3K | 0.1% | 00.0% | Unchanged | History |
| BOLTBolt Biotherapeutics, Inc. | COM | 626,109 | $250.4K | 0.1% | 00.0% | Unchanged | History |
| SENSSenseonics Holdings, Inc. | COM | 43,426 | $28.5K | <0.1% | 00.0% | Unchanged | History |
| DNAGinkgo Bioworks Holdings, Inc. | CL A NEW | 2,928 | $16.7K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q4 2024 (2)
Positions held at the end of Q4 2024 that are gone from this filing.